<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36293857</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>20</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>14</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>New-Onset Diabetes Mellitus, Hypertension, Dyslipidaemia as Sequelae of COVID-19 Infection-Systematic Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">13280</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph192013280</ELocationID><Abstract><AbstractText>As the population recovers from the coronavirus disease 2019 (COVID-19) pandemic, a subset of individuals is emerging as post-coronavirus disease (post-COVID) patients who experience multifactorial long-term symptoms several weeks after the initial recovery from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The aim of this systematic review is to present the latest scientific reports that evaluate changes in glucose levels, blood pressure readings and lipid profiles after recovery from COVID-19 to verify the hypothesis that new-onset diabetes mellitus, arterial hypertension and dyslipidaemia are a possible sequela of a COVID-19 infection. The open access databases PubMed and Google Scholar were searched. Articles investigating patients with residual clinical signs and biochemical alteration indicating diabetes, hypertension and dyslipidaemia at least a month after recovering from COVID-19 were included. It has been shown that a select number of patients were diagnosed with new-onset diabetes, arterial hypertension and dyslipidaemia after COVID-19 infection. Alterations in glucose levels, blood pressure and lipid profiles months after initial infection shows the importance of considering diabetes mellitus, arterial hypertension and dyslipidaemia as part of the multifactorial diagnostic criteria post-COVID to better provide evidence-based clinical care.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wrona</LastName><ForeName>Marysia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Poznan University of Medical Sciences, 61-701 Poznan, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skrypnik</LastName><ForeName>Damian</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-5643-6899</Identifier><AffiliationInfo><Affiliation>Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences, 60-569 Poznan, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>502-14-21191730-11315 ; ID: 4089</GrantID><Agency>Poznan University of Medical Sciences</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance UI="D005947">Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008055">Lipids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="Y">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050171" MajorTopicYN="Y">Dyslipidemias</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008055" MajorTopicYN="N">Lipids</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 sequelae</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">new-onset diabetes mellitus</Keyword><Keyword MajorTopicYN="N">new-onset dyslipidaemia</Keyword><Keyword MajorTopicYN="N">new-onset hypertension</Keyword><Keyword MajorTopicYN="N">post-COVID</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>27</Day><Hour>1</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36293857</ArticleId><ArticleId IdType="pmc">PMC9602450</ArticleId><ArticleId IdType="doi">10.3390/ijerph192013280</ArticleId><ArticleId IdType="pii">ijerph192013280</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Centers for Disease Control and Prevention  Post-COVID Conditions. Centers for Disease Control and Prevention. Retrieved 10 March 2022.  [(accessed on 16 September 2021)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>Pavli A., Theodoridou M., Maltezou H.C. Post-COVID syndrome: Incidence, clinical spectrum and challenges for primary healthcare professionals. Arch. Med. Res. 2021;52:575&#x2013;581. doi: 10.1016/j.arcmed.2021.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2021.03.010</ArticleId><ArticleId IdType="pmc">PMC8093949</ArticleId><ArticleId IdType="pubmed">33962805</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehar S., Boushra M., Ntiamoah P., Biehl M. Post-Acute sequelae of SARS-CoV-2 infection: Caring for the &#x2018;long-Haulers. Clevel. Clin. J. Med. 2021;88:267&#x2013;272. doi: 10.3949/ccjm.88a.21010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3949/ccjm.88a.21010</ArticleId><ArticleId IdType="pubmed">33941600</ArticleId></ArticleIdList></Reference><Reference><Citation>NHS  Long-Term Effects of Coronavirus (Long COVID). NHS Choices.  [(accessed on 10 March 2022)].  Available online:  https://www.nhs.uk/conditions/coronavirus-COVID-19/long-Term-Effects-of-Coronavirus-Long-Covid.</Citation></Reference><Reference><Citation>World Health Organisation. (n.d.)  Coronavirus Disease (COVID-19): Post COVID-19 Condition. World Health Organisation.  [(accessed on 10 March 2022)].  Available online:  https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(COVID-19)-post-covid-19-condition.</Citation></Reference><Reference><Citation>Daugherty S.E., Guo Y., Heath K., Dasmari&#xf1;as M.C., Jubilo K.G., Samranvedhya J., Lipsitch M., Cohen K. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: Retrospective cohort study. BMJ. 2021;373:n1098. doi: 10.1136/bmj.n1098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha D.B., Budhathoki P., Raut S., Adhikari S., Ghimire P., Thapaliya S., Rabaan A.A., Karki B.J. New-Onset diabetes in COVID-19 and clinical outcomes: A systematic review and meta-analysis. World J. Virol. 2021;10:275&#x2013;287. doi: 10.5501/wjv.v10.i5.275.</Citation><ArticleIdList><ArticleId IdType="doi">10.5501/wjv.v10.i5.275</ArticleId><ArticleId IdType="pmc">PMC8474977</ArticleId><ArticleId IdType="pubmed">34631477</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhamad S.-A., Ugusman A., Kumar J., Skiba D., Hamid A.A., Aminuddin A. COVID-19 and hypertension: The what, the why and the how. Front. Physiol. 2021;12:665064. doi: 10.3389/fphys.2021.665064.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.665064</ArticleId><ArticleId IdType="pmc">PMC8126692</ArticleId><ArticleId IdType="pubmed">34012410</ArticleId></ArticleIdList></Reference><Reference><Citation>Montefusco L., Ben Nasr M., D&#x2019;Addio F., Loretelli C., Rossi A., Pastore I., Daniele G., Abdelsalam A., Maestroni A., Dell&#x2019;Acqua M., et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat. Metab. 2021;3:774&#x2013;785. doi: 10.1038/s42255-021-00407-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00407-6</ArticleId><ArticleId IdType="pmc">PMC9931026</ArticleId><ArticleId IdType="pubmed">34035524</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M., Zhu B., Chen D., Hu X., Xu X., Shen W.J., Hu C., Li J., Qu S. COVID-19 may increase the risk of insulin resistance in adult patients without diabetes: A 6-Month prospective study. Endocr. Pract. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol. 2021;27:834&#x2013;841. doi: 10.1016/j.eprac.2021.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2021.04.004</ArticleId><ArticleId IdType="pmc">PMC8054613</ArticleId><ArticleId IdType="pubmed">33887468</ArticleId></ArticleIdList></Reference><Reference><Citation>Nesan G., Keerthana D., Yamini R., Jain T., Kumar D., Eashwer A., Maiya G.R. 3-month symptom-based ambidirectional follow-up study among recovered COVID-19 patients from a tertiary care hospital using telehealth in Chennai, India. Inq. J. Med. Care Organ. Provis. Financ. 2021;58:469580211060165. doi: 10.1177/00469580211060165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00469580211060165</ArticleId><ArticleId IdType="pmc">PMC8721686</ArticleId><ArticleId IdType="pubmed">34915771</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Khunti K., Nafilyan V., Maddox T., Humberstone B., Diamond I., Banerjee A. Post-COVID syndrome in individuals admitted to hospital with COVID-19: Retrospective cohort study. BMJ. 2021;372:n693. doi: 10.1136/bmj.n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-Month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Akpek M. Does COVID-19 cause hypertension? Angiology. 2021;73:33197211053903. doi: 10.1177/00033197211053903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00033197211053903</ArticleId><ArticleId IdType="pmc">PMC9260192</ArticleId><ArticleId IdType="pubmed">34889662</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lorenzo R., Conte C., Lanzani C., Benedetti F., Roveri L., Mazza M.G., Brioni E., Giacalone G., Canti V., Sofia V., et al. Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study. PLoS ONE. 2020;15:e0239570. doi: 10.1371/journal.pone.0239570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0239570</ArticleId><ArticleId IdType="pmc">PMC7556454</ArticleId><ArticleId IdType="pubmed">33052920</ArticleId></ArticleIdList></Reference><Reference><Citation>Gameil M.A., Marzouk R.E., Elsebaie A.H., Rozaik S.E., Journal E.L. Long-Term clinical and biochemical residue after COVID-19 recovery. Egypt Liver J. 2021;11:74. doi: 10.1186/s43066-021-00144-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43066-021-00144-1</ArticleId><ArticleId IdType="pmc">PMC8435147</ArticleId><ArticleId IdType="pubmed">34777873</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Wamil M., Alberts J., Oben J., Cuthbertson D.J., Wootton D., Crooks M., Gabbay M., Brady M., Hishmeh L., et al. Multiorgan impairment in low-Risk individuals with post-COVID-19 syndrome: A prospective, community-Based study. BMJ Open. 2021;11:e048391. doi: 10.1136/bmjopen-2020-048391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Moore M.J., Vasllieva N., Sui J., Wong S.K., Berne M.A. Angiotensin-Converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450&#x2013;454. doi: 10.1038/nature02145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02145</ArticleId><ArticleId IdType="pmc">PMC7095016</ArticleId><ArticleId IdType="pubmed">14647384</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee M., Pal R., Dutta S. Risk of incident diabetes post-COVID-19: A systematic review and meta-Analysis. Prim. Care Diabetes. 2022;16:591&#x2013;593. doi: 10.1016/j.pcd.2022.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcd.2022.05.009</ArticleId><ArticleId IdType="pmc">PMC9148988</ArticleId><ArticleId IdType="pubmed">35654679</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Long X., Zhang B., Zhang W., Chen X., Zhang Z. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc. 2022;18:2128&#x2013;2130.e2. doi: 10.1016/j.cgh.2020.04.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2020.04.040</ArticleId><ArticleId IdType="pmc">PMC7194639</ArticleId><ArticleId IdType="pubmed">32334082</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J., Mackie S.L., Pujades-Rodriguez M. Glucocorticoid dose-Dependent risk of type 2 diabetes in six immune-Mediated inflammatory diseases: A population-based cohort analysis. BMJ. Open. Diabetes. Res. Care. 2020;8:e001220. doi: 10.1136/bmjdrc-2020-001220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjdrc-2020-001220</ArticleId><ArticleId IdType="pmc">PMC7389515</ArticleId><ArticleId IdType="pubmed">32719077</ArticleId></ArticleIdList></Reference><Reference><Citation>Oudit G.Y., Kassiri Z., Jiang C., Liu P.P., Poutanen S.M., Penninger J.M. SARS-Coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur. J. Clin. Investig. 2009;39:618&#x2013;625. doi: 10.1111/j.1365-2362.2009.02153.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2362.2009.02153.x</ArticleId><ArticleId IdType="pmc">PMC7163766</ArticleId><ArticleId IdType="pubmed">19453650</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaharuddin S.H., Wang V., Santos R.S., Gross A., Wang Y., Jawanda H., Zhang Y., Hasan W., Garcia G., Jr., Arumugaswami V., et al. Deleterious effects of SARS-CoV-2 infection on human pancreatic cells. Front. Cell. Infect. Microbiol. 2021;11:678482. doi: 10.3389/fcimb.2021.678482.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.678482</ArticleId><ArticleId IdType="pmc">PMC8285288</ArticleId><ArticleId IdType="pubmed">34282405</ArticleId></ArticleIdList></Reference><Reference><Citation>Melvin W.J., Audu C.O., Davis F.M., Sharma S.B., Joshi A., DenDekker A., Wolf S., Barrett E., Mangum K., Zhou X., et al. Coronavirus induces diabetic macrophage-Mediated inflammation via SETDB2. Proc. Natl. Acad. Sci. USA. 2021;118:e2101071118. doi: 10.1073/pnas.2101071118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2101071118</ArticleId><ArticleId IdType="pmc">PMC8463849</ArticleId><ArticleId IdType="pubmed">34479991</ArticleId></ArticleIdList></Reference><Reference><Citation>Catriona C., Paolo P. SARS-CoV-2 induced post-Translational protein modifications: A trigger for developing autoimmune diabetes? Diabetes/Metab. Res. Rev. 2022;38:e3508. doi: 10.1002/dmrr.3508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.3508</ArticleId><ArticleId IdType="pmc">PMC9015335</ArticleId><ArticleId IdType="pubmed">34990520</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock C., Richter S., Berger I., Barovic M., Schmid J., Schubert U., Jarzebska N., von M&#xe4;ssenhausen A., Linkermann A., Sch&#xfc;rmann A. Viral infiltration of pancreatic islets in patients with COVID-19. Nat. Commun. 2021;12:3534. doi: 10.1038/s41467-021-23886-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23886-3</ArticleId><ArticleId IdType="pmc">PMC8192507</ArticleId><ArticleId IdType="pubmed">34112801</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner C., Griesel M., Mikolajewska A., Mueller A., Nothacker M., Kley K., Metzendorf M.I., Fischer A.L., Kopp M., Stegemann M., et al. Systemic corticosteroids for the treatment of COVID-19. Cochrane Database Syst. Rev. 2021;8:CD014963. doi: 10.1002/14651858.CD014963.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD014963</ArticleId><ArticleId IdType="pmc">PMC8406706</ArticleId><ArticleId IdType="pubmed">34396514</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock C., Schwarz P., Ludwig B., Linkermann A., Zimmet P., Kulebyakin K., Tkachuk V.A., Markov A.G., Lehnert H., de Angelis M.H., et al. COVID-19 and metabolic disease: Mechanisms and clinical management. Lancet. Diabetes Endocrinol. 2021;9:786&#x2013;798. doi: 10.1016/S2213-8587(21)00244-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(21)00244-8</ArticleId><ArticleId IdType="pmc">PMC8489878</ArticleId><ArticleId IdType="pubmed">34619105</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q., Zhou L., Sun X., Yan Z., Hu C., Wu J. Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci. Rep. 2017;7:9110. doi: 10.1038/s41598-017-09536-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-09536-z</ArticleId><ArticleId IdType="pmc">PMC5567209</ArticleId><ArticleId IdType="pubmed">28831119</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirchdoerfer R.N., Cottrell C.A., Wang N., Pallesen J., Yassine H.M., Turner H.L., Corbett K.S., Graham B.S., McLellan J.S., Ward A.B. Pre-Fusion structure of a human coronavirus spike. Protein. Nat. 2016;531:118&#x2013;121. doi: 10.1038/nature17200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature17200</ArticleId><ArticleId IdType="pmc">PMC4860016</ArticleId><ArticleId IdType="pubmed">26935699</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaduganathan M., Vardeny O., Michel T., McMurray J., Pfeffer M.A., Solomon S.D. Renin-Angiotensin-Aldosterone system inhibitors in patients with COVID-19. N. Engl. J. Med. 2020;382:1653&#x2013;1659. doi: 10.1056/NEJMsr2005760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsr2005760</ArticleId><ArticleId IdType="pmc">PMC7121452</ArticleId><ArticleId IdType="pubmed">32227760</ArticleId></ArticleIdList></Reference><Reference><Citation>Annweiler Z., Cao Y., Wu E., Faucon S., Mouhat H., Kovacic J., Sabatier M. Counter-regulatory &#x2018;renin-Angiotensin&#x2019; system-Based candidate drugs to treat COVID-19 diseases in SARS-CoV-2-Infected patients. Infect. Disord.-Drug Targets. 2020;20:407&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pubmed">32418532</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Mart&#xed;nez A.B., Torres-Perez E., Devanney N., del Moral R., Johnson L.A., Arbones-Mainar J.M. Beyond the CNS: The many peripheral roles of APOE. Neurobiol. Dis. 2020;138:104809. doi: 10.1016/j.nbd.2020.104809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104809</ArticleId><ArticleId IdType="pmc">PMC7195217</ArticleId><ArticleId IdType="pubmed">32087284</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker J., Ayenew W., Quick H., Hullsiek K.H., Tracy R., Henry K. High-Density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection. J. Infect. Dis. 2010;201:285&#x2013;292. doi: 10.1086/649560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/649560</ArticleId><ArticleId IdType="pmc">PMC2798007</ArticleId><ArticleId IdType="pubmed">19954384</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorokin A.V., Karathanasis S.K., Yang Z.H., Freeman L., Kotani K., Remaley A.T. COVID-19-Associated dyslipidaemia: Implications for mechanism of impaired resolution and novel therapeutic approaches. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2020;34:9843&#x2013;9853. doi: 10.1096/fj.202001451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202001451</ArticleId><ArticleId IdType="pmc">PMC7361619</ArticleId><ArticleId IdType="pubmed">32588493</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaji H. High-Density lipoproteins and the immune system. J. Lipids. 2013;2013:684903. doi: 10.1155/2013/684903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/684903</ArticleId><ArticleId IdType="pmc">PMC3572698</ArticleId><ArticleId IdType="pubmed">23431458</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Lei J., Li Z., Yan L. Potential effects of coronaviruses on the liver: An update. Front. Med. 2021;8:651658. doi: 10.3389/fmed.2021.651658.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.651658</ArticleId><ArticleId IdType="pmc">PMC8502894</ArticleId><ArticleId IdType="pubmed">34646834</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E., Levi R., Sarti R., Pozzi C., Mollura M., Mantovani A., Rescigno M. Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers. JAMA. 2022;328:676&#x2013;678. doi: 10.1001/jama.2022.11691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11691</ArticleId><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>